BindingDB logo
myBDB logout

11 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27474919 10 Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency.EBI National Cheng-Kung University
26838810 16 Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful▀-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal▀-galactosidase.EBI Graz University of Technology
15771446 42 Biological properties of D- and L-1-deoxyazasugars.EBI Toyama Medical and Pharmaceutical University
9651160 52 Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.EBI Hokuriku University
20457528 22 2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.EBI University of Toyama
 37 Synthesis of a new inhibitor of α-fucosidaseEBI TBA
 5 Synthesis of C2-symmetrical polyhydroxyazepanes as inhibitors of glycosidasesEBI TBA
14684301 3 Novel O-glycosyl amino acid mimetics as building blocks for O-glycopeptides act as inhibitors of galactosidases.EBI University of Hamburg
10560746 10 Revised structure of a homonojirimycin isomer from Aglaonema treubii: first example of a naturally occurring alpha-homoallonojirimycin.EBI Institut de Chimie Organique et Analytique (I.C.O.A.)
10021944 8 Specific, uncompetitive inhibition of beta-galactosidases by a 5,6-isopropylidenedioxyfuro[2,3-d]isoxazole-3-methanol derivative.EBI Institut de chimie organique de l'Université de Lausanne
24783948 14 Molecular Basis of 1-Deoxygalactonojirimycin Arylthiourea Binding to Human a-Galactosidase A: Pharmacological Chaperoning Efficacy on Fabry Disease Mutants.BDB Tottori University , Yonago 683-8503, Japan